Last September, Octane hosted the highly anticipated Cardiovascular Tech Forum at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point. This annual event has become a cornerstone for healthcare industry professionals seeking insights into the latest trends, innovations, and challenges in cardiovascular technology.
The Apex Of Innovation
Under the theme “The Apex Of Innovation,” the event showcased cutting-edge technologies and therapies aimed at tackling cardiovascular disease. Attendees were immersed in a world of advancements, from heart failure management to aortic diseases, pediatric initiatives, and groundbreaking first-in-human trials for 2022. Emerging cardiac companies also took the stage, presenting their latest innovations to an eager audience.
Emcee Extraordinaire: Dr. Maria Berkman
Leading the event as emcee was Dr. Maria Berkman, MD, MBA, Head of Medtech at Broadview Ventures and Managing Director of Longview Ventures. Dr. Berkman’s extensive experience and passion for improving patient outcomes made her the ideal guide for navigating the forum’s discussions and insights.
Key Highlights
- Keynote Address by Todd Brinton: Renowned thought leader Todd Brinton, Chief Scientific Officer at Edwards and Founder & Medical Director of Shockwave, delivered a transformative keynote on driving innovation in cardiovascular healthcare.
- Panel Discussions: Industry experts like Philip B Adamson, M.D. MSc, FACC, Steve Hanle from Stradling, and Andrew Douglas from Knobbe Martens led engaging panel discussions on emerging technologies and their impact on patient care.
- Interactive Sessions: Collaborative initiatives and in-depth analyses of current buying trends provided valuable perspectives for strategics and investors, with notable contributions from leaders like William C. Wilson from Masimo and Dr. Anthony Caffarelli from Hoag.
- Capital & Growth Presentations: The forum also featured presentations from Capital & Growth companies, showcasing successful implementations of innovative cardiovascular solutions.
Celebrating Success with Incredible Sponsors
The success of the Cardiovascular Tech Forum 2023 wouldn’t have been possible without the support of our incredible sponsors. A special thank you to our Founding sponsor, InQB8 Medical Technologies, whose vision and dedication helped shape this event. We also extend our gratitude to sponsors like Edwards Lifesciences, Biosense Webster, American Heart Association, Avania, CathWorks, Hoag, ICON, Knobbe Martens, Masimo, NXT Biomedical, Renata Medical, Stradling, and many more, whose contributions were instrumental in making this summit a resounding success.
Looking Ahead to 2024
As the curtain fell on Cardiovascular Tech Forum 2023, excitement for the future surged with a plug for the 2024 Cardiovascular Tech Forum, set to take place on September 12-13, 2024, at the VEA Newport Beach, A Marriott Resort & Spa. The 2024 theme, “Catalyzing Change in Cardiovascular Care: The Power of Collaboration,” promises a deep dive into the transformative impact of collaboration on cardiovascular care, from pioneering research to groundbreaking technologies. Tickets are on sale now. Register here!
Join us as we unlock the potential of collaboration to drive innovation and enhance patient outcomes in cardiovascular healthcare.
0 Comments